Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
|Articles|March 12, 2013
Supplements and Featured Publications
- Managing Costs in High-Risk Obstetrics
Managing Costs in High-Risk Obstetrics
Author(s)Maria Lopes, MD, MS
Advertisement
Premature birth is responsible for an estimated $26 billion in costs to the American healthcare system annually, with high-risk pregnancies constituting a major category of high cost. Spontaneous preterm births due to preterm labor or preterm premature rupture of membranes represent the majority of all preterm births. This article identifies ways in which new technology can improve the diagnostic accuracy of pregnancy-related disorders and assist in managing the costs of high-risk obstetrics.
To access the publication, “Managing Costs in High-Risk Obstetrics,” please click on the image below.
Advertisement
Related to this article
Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, diffuse-type disease.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
The pilot pairs grocery stipends and community health worker support with members who have unmanaged diabetes and unmet social needs.
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
3
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
4
Pulmonary Embolism Can Affect Elite Athletes, Too: Samantha Pettigrew, MD
5